Mar, 11 2026
Biologic patent protection in the U.S. delays biosimilar entry for up to 12 years, keeping drug prices high. Learn how the BPCIA, patent thickets, and development costs block competition - and what it means for patients.
Jan, 11 2026
Patent exclusivity and market exclusivity are two separate legal tools that protect new drugs. Patents cover inventions; market exclusivity blocks generic approval. Understanding both explains why drug prices stay high even after patents expire.